コンパニオンアニマル用ワクチン市場、規模、シェア、動向、産業分析レポート：投与経路別、製品タイプ別、動物タイプ別、流通チャネル別、地域別、2025年～2034年の市場予測

Polaris Market Research社の最新調査によると、コンパニオンアニマル用ワクチンの市場規模は2034年までに85億656万米ドルに達する見込みです。本レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

コンパニオンアニマル用ワクチン市場は、犬や猫などの家畜以外のペットを様々な感染症から守るために開発された生物学的製剤で構成されています。この市場は、ペットの人間化が進み、飼い主が予防ヘルスケアをますます優先するようになるにつれて、進化し続けています。動物免疫学の進歩は、人獣共通感染症のリスクに対する意識の高まりと相まって、中核ワクチンと非中核ワクチンの両方に対する旺盛な需要を牽引しています。業界では、コンプライアンスと安全性を高めるため、混合ワクチンや、針を使わない注射器や経口製剤などの新しいデリバリー・プラットフォームの採用が増加しています。また、家庭動物におけるウイルスや細菌感染の増加も、ワクチン開発、特に組換え技術やDNAベース技術の革新に拍車をかけています。

市場成長は、ペット保険の適用範囲拡大や動物医療費の増加によって加速しており、これらは総体的にワクチンの普及を後押ししています。市場開拓企業は、進化する病原体プロファイルや抗原変異性に対応し、長時間作用型、交差防御型、株特異的ワクチンを開発するための研究開発に投資しています。厳しい規制監督により製品の有効性と安全性が保証されるため、メーカーは高度な品質保証の実践に取り組んでいます。個別化された動物医療や、ワクチン開発パイプラインへの人工知能（AI）の応用は、市場投入までの時間を短縮し、ターゲティング精度を向上させる好機です。ワクチンの認知度向上における動物病院とデジタルヘルスプラットフォームの役割の増大は、製薬会社と動物病院の協力関係の増大と相まって、市場拡大の好展開を示唆しています。

コンパニオンアニマル用ワクチン市場レポートハイライト

製品別では、2024年には、弱毒生ワクチン分野が、その強固な免疫原性と迅速な防御開始により、最大のシェアを占めました。

動物の種類別では、猫白血病ウイルス（FeLV）や猫免疫不全ウイルス（FIV）のような猫特有の病原体に対する意識の高まりにより、予測期間中、猫セグメントが最も高いCAGRを示すと予想されます。

2024年、北米コンパニオンアニマル用ワクチン市場は、同地域の厳格なペットワクチン接種法、高い獣医療サービス利用率、強力な医薬品R&Dの存在により、最大のシェアを占めました。

アジア太平洋コンパニオンアニマル用ワクチン市場は、特に中国、インド、東南アジアなどの新興国におけるペット数の急速な増加により、予測期間中に最も高いCAGRを記録すると予測されています。

世界の主要市場プレーヤーには、Zoetis、Merck &Co., Inc.、Boehringer Ingelheim Animal Health、Elanco、Virbac、Phibro Animal Health Corporation、Calier、Ceva、Bimeda Biologicals、Neogen Corporationなどがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 コンパニオンアニマル用ワクチン市場の洞察

• 市場スナップショット
• コンパニオンアニマル用ワクチン市場力学
  • 促進要因と機会
    • ペット飼育の増加とペットの人間化
    • 人獣共通感染症に対する意識の高まり
  • 抑制要因と課題
    • 高コスト
• PESTEL分析
• コンパニオンアニマル用ワクチン市場パワー評価動向
• バリューチェーン分析

第5章 コンパニオンアニマル用ワクチン市場：製品別

• 主な調査結果
• イントロダクション
• 弱毒生ワクチン
• 不活化ワクチン
• サブユニットワクチン
• DNAワクチン
• 組み換えワクチン

第6章 コンパニオンアニマル用ワクチン市場：投与経路別

• 主な調査結果
• イントロダクション
• 皮下
• 筋肉内
• 鼻腔内

第7章 コンパニオンアニマル用ワクチン市場：動物タイプ別

• 主な調査結果
• イントロダクション
• イヌ
• イヌ
• その他

第8章 コンパニオンアニマル用ワクチン市場：流通チャネル別

• 主な調査結果
• イントロダクション
• 小売り
• eコマース
• 病院/クリニック薬局

第9章 コンパニオンアニマル用ワクチン市場：地域別

• 主な調査結果
• イントロダクション
  • コンパニオンアニマル用ワクチン市場分析：地域別、2020年～2034年
• 北米
  • 北米：製品別、2020～2034年
  • 北米：投与経路別、2020～2034年
  • 北米：流通チャネル別、2020～2034年
  • 北米：動物タイプ別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：製品別、2020～2034年
  • 欧州：投与経路別、2020～2034年
  • 欧州：流通チャネル別、2020～2034年
  • 欧州：動物タイプ別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋地域
  • アジア太平洋地域：製品別、2020～2034年
  • アジア太平洋地域：投与経路別、2020～2034年
  • アジア太平洋地域：流通チャネル別、2020～2034年
  • アジア太平洋地域：動物タイプ別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：製品別、2020～2034年
  • 中東・アフリカ：投与経路別、2020～2034年
  • 中東・アフリカ：流通チャネル別、2020～2034年
  • 中東・アフリカ：動物タイプ別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ
• ラテンアメリカ
  • ラテンアメリカ：製品別、2020～2034年
  • ラテンアメリカ：投与経路別、2020～2034年
  • ラテンアメリカ：流通チャネル別、2020～2034年
  • ラテンアメリカ：動物タイプ別、2020-2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Bimeda Biologicals
• Boehringer Ingelheim Animal Health
• Calier
• Ceva
• Elanco
• Merck & Co., Inc.
• Neogen Corporation
• Phibro Animal Health Corporation
• Virbac
• Zoetis

List of Tables:

• Table 1 Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 2 Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 3 Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 4 Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 5 North America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 6 North America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 7 North America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 8 North America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 9 US: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 10 US: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 11 US: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 12 US: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 13 Canada: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 14 Canada: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 15 Canada: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 16 Canada: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 17 Europe: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 18 Europe: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 19 Europe: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 20 Europe: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 21 UK: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 22 UK: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 23 UK: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 24 UK: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 25 France: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 26 France: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 27 France: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 28 France: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 29 Germany: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 30 Germany: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 31 Germany: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 32 Germany: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 33 Italy: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 34 Italy: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 35 Italy: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 36 Italy: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 37 Spain: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 38 Spain: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 39 Spain: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 40 Spain: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 41 Netherlands: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 42 Netherlands: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 43 Netherlands: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 44 Netherlands: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 45 Russia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 46 Russia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 47 Russia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 48 Russia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 49 Rest of Europe: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 50 Rest of Europe: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 51 Rest of Europe: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 52 Rest of Europe: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 53 Asia Pacific: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 54 Asia Pacific: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 55 Asia Pacific: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 56 Asia Pacific: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 57 China: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 58 China: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 59 China: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 60 China: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 61 India: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 62 India: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 63 India: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 64 India: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 65 Malaysia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 66 Malaysia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 67 Malaysia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 68 Malaysia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 69 Japan: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 70 Japan: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 71 Japan: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 72 Japan: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 73 Indonesia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 74 Indonesia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 75 Indonesia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 76 Indonesia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 77 South Korea: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 78 South Korea: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 79 South Korea: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 80 South Korea: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 81 Australia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 82 Australia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 83 Australia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 84 Australia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 85 Rest of Asia Pacific: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 86 Rest of Asia Pacific: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 87 Rest of Asia Pacific: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 88 Rest of Asia Pacific: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 89 Middle East & Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 90 Middle East & Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 91 Middle East & Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 92 Middle East & Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 93 Saudi Arabia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 94 Saudi Arabia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 95 Saudi Arabia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 96 Saudi Arabia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 97 UAE: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 98 UAE: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 99 UAE: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 100 UAE: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 101 Israel: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 102 Israel: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 103 Israel: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 104 Israel: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 105 South Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 106 South Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 107 South Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 108 South Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 109 Rest of Middle East & Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 110 Rest of Middle East & Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 111 Rest of Middle East & Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 112 Rest of Middle East & Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 113 Latin America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 114 Latin America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 115 Latin America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 116 Latin America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 117 Mexico: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 118 Mexico: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 119 Mexico: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 120 Mexico: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 121 Brazil: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 122 Brazil: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 123 Brazil: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 124 Brazil: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 125 Argentina: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 126 Argentina: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 127 Argentina: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 128 Argentina: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• Table 129 Rest of Latin America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
• Table 130 Rest of Latin America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• Table 131 Rest of Latin America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• Table 132 Rest of Latin America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)

List of Figures:

• Figure 1. Companion Animal Vaccines Market, 2020-2034 (USD Million)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Product
• Figure 7. Companion Animal Vaccines Market, By Product, 2024 & 2034 (USD Million)
• Figure 8. Market by Route of Administration
• Figure 9. Companion Animal Vaccines Market, By Route of Administration, 2024 & 2034 (USD Million)
• Figure 10. Market by Distribution Channel
• Figure 11. Companion Animal Vaccines Market, by Distribution Channel, 2024 & 2034 (USD Million)
• Figure 12. Market by Animal Type
• Figure 13. Companion Animal Vaccines Market, by Animal Type, 2024 & 2034 (USD Million)

The companion animal vaccines market size is expected to reach USD 8,506.56 million by 2034, according to a new study by Polaris Market Research. The report "Companion Animal Vaccines Market Size, Share, Trends, & Industry Analysis Report: By Route of Administration (Subcutaneous, Intramuscular, and Intranasal), By Product, By Animal Type, By Distribution Channel, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The companion animal vaccines market comprises biologic products developed to protect domestic pets such as dogs, cats, and other non-livestock animals from various infectious diseases. This market continues to evolve as pet humanization intensifies and pet owners increasingly prioritize preventative healthcare. Advancements in veterinary immunology, coupled with rising awareness of zoonotic disease risks, are driving robust demand for both core and non-core vaccines. The industry is witnessing increased adoption of combination vaccines and novel delivery platforms, such as needle-free injectors and oral formulations, enhancing compliance and safety. Rising incidences of viral and bacterial infections in household animals have also catalyzed innovation in vaccine development, particularly in recombinant and DNA-based technologies.

The market growth is accelerated by the expansion of pet insurance coverage and greater veterinary healthcare expenditure, which collectively support higher vaccine uptake. Market players are investing in R&D to develop long-acting, cross-protective, and strain-specific vaccines, responding to evolving pathogen profiles and antigenic variability. Stringent regulatory oversight ensures product efficacy and safety, prompting manufacturers to integrate advanced quality assurance practices. Opportunities lie in personalized veterinary medicine and the application of artificial intelligence (AI) in vaccine development pipelines, which shorten time-to-market and improve targeting accuracy. The increasing role of veterinary clinics and digital health platforms in raising vaccine awareness, coupled with growing collaboration between pharmaceutical firms and veterinary institutions, signals a favorable outlook for market expansion.

Companion Animal Vaccines Market Report Highlights

By product, in 2024, the attenuated live vaccines segment held the largest share due to their robust immunogenicity and rapid onset of protection.

Based on animal type, the feline segment is expected to witness the highest CAGR during the forecast period due to increasing awareness around feline-specific pathogens such as feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV).

In 2024, the North America companion animal vaccines market held the largest share due to the region's stringent pet vaccination laws, high veterinary service utilization, and strong pharmaceutical R&D presence.

The Asia Pacific companion animal vaccines market is projected to register the highest CAGR during the forecast period, driven by a rapidly growing pet population, particularly in emerging economies such as China, India, and Southeast Asia.

A few global key market players include Zoetis; Merck & Co., Inc.; Boehringer Ingelheim Animal Health; Elanco; Virbac; Phibro Animal Health Corporation; Calier; Ceva; Bimeda Biologicals; and Neogen Corporation.

Polaris Market Research has segmented the market report on the basis of product, route of administration, animal type, distribution channel, and region:

By Product Outlook (Revenue, USD Million, 2020-2034)

Attenuated Live Vaccines

Inactivated Vaccines

Subunit Vaccines

DNA Vaccines

Recombinant Vaccines

By Route of Administration Outlook (Revenue, USD Million, 2020-2034)

Subcutaneous

Intramuscular

Intranasal

By Animal Type Outlook (Revenue, USD Million, 2020-2034)

Canine

Feline

Others

By Distribution Channel Outlook (Revenue, USD Million, 2020-2034)

Retail

E-Commerce

Hospital/Clinic Pharmacy

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Companion Animal Vaccines Market Insights

• 4.1. Companion Animal Vaccines Market - Market Snapshot
• 4.2. Companion Animal Vaccines Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing Pet Ownership and Humanization of Pets
    • 4.2.1.2. Growing Awareness About Zoonotic Diseases
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High Costs
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Companion Animal Vaccines Market Power Rating Trends
• 4.6. Value Chain Analysis

5. Companion Animal Vaccines Market, by Product

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Companion Animal Vaccines Market, by Product, 2020-2034 (USD Million)
• 5.3. Attenuated Live Vaccines
  • 5.3.1. Companion Animal Vaccines Market, by Attenuated Live Vaccines, by Region, 2020-2034 (USD Million)
• 5.4. Inactivated Vaccines
  • 5.4.1. Companion Animal Vaccines Market, by Inactivated Vaccines, by Region, 2020-2034 (USD Million)
• 5.5. Subunit Vaccines
  • 5.5.1. Companion Animal Vaccines Market, by Subunit Vaccines, by Region, 2020-2034 (USD Million)
• 5.6. DNA Vaccines
  • 5.6.1. Companion Animal Vaccines Market, by DNA Vaccines, by Region, 2020-2034 (USD Million)
• 5.7. Recombinant Vaccines
  • 5.7.1. Companion Animal Vaccines Market, by Recombinant Vaccines, by Region, 2020-2034 (USD Million)

6. Companion Animal Vaccines Market, by Route of Administration

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
• 6.3. Subcutaneous
  • 6.3.1. Companion Animal Vaccines Market, by Subcutaneous, by Region, 2020-2034 (USD Million)
• 6.4. Intramuscular
  • 6.4.1. Companion Animal Vaccines Market, by Intramuscular, by Region, 2020-2034 (USD Million)
• 6.5. Intranasal
  • 6.5.1. Companion Animal Vaccines Market, by Intranasal, by Region, 2020-2034 (USD Million)

7. Companion Animal Vaccines Market, by Animal Type

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• 7.3. Canine
  • 7.3.1. Companion Animal Vaccines Market, by Canine, by Region, 2020-2034 (USD Million)
• 7.4. Feline
  • 7.4.1. Companion Animal Vaccines Market, by Feline, by Region, 2020-2034 (USD Million)
• 7.5. Other
  • 7.5.1. Companion Animal Vaccines Market, by Other, by Region, 2020-2034 (USD Million)

8. Companion Animal Vaccines Market, by Distribution Channel

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
• 8.3. Retail
  • 8.3.1. Companion Animal Vaccines Market, by Retail, by Region, 2020-2034 (USD Million)
• 8.4. E-Commerce
  • 8.4.1. Companion Animal Vaccines Market, by E-Commerce, by Region, 2020-2034 (USD Million)
• 8.5. Hospital/ Clinic Pharmacy
  • 8.5.1. Companion Animal Vaccines Market, by Hospital/ Clinic Pharmacy, by Region, 2020-2034 (USD Million)

9. Companion Animal Vaccines Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Companion Animal Vaccines Market Assessment, By Geography, 2020-2034 (USD Million)
• 9.3. Companion Animal Vaccines Market - North America
  • 9.3.1. North America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  • 9.3.2. North America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  • 9.3.3. North America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  • 9.3.4. North America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.3.5. Companion Animal Vaccines Market - US
    • 9.3.5.1. US: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.3.5.2. US: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.3.5.3. US: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.3.5.4. US: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.3.6. Companion Animal Vaccines Market - Canada
    • 9.3.6.1. Canada: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.3.6.2. Canada: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.3.6.3. Canada: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.3.6.4. Canada: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• 9.4. Companion Animal Vaccines Market - Europe
  • 9.4.1. Europe: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  • 9.4.2. Europe: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  • 9.4.3. Europe: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  • 9.4.4. Europe: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.4.5. Companion Animal Vaccines Market - UK
    • 9.4.5.1. UK: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.4.5.2. UK: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.4.5.3. UK: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.4.5.4. UK: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.4.6. Companion Animal Vaccines Market - France
    • 9.4.6.1. France: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.4.6.2. France: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.4.6.3. France: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.4.6.4. France: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.4.7. Companion Animal Vaccines Market - Germany
    • 9.4.7.1. Germany: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.4.7.2. Germany: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.4.7.3. Germany: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.4.7.4. Germany: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.4.8. Companion Animal Vaccines Market - Italy
    • 9.4.8.1. Italy: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.4.8.2. Italy: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.4.8.3. Italy: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.4.8.4. Italy: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.4.9. Companion Animal Vaccines Market - Spain
    • 9.4.9.1. Spain: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.4.9.2. Spain: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.4.9.3. Spain: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.4.9.4. Spain: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.4.10. Companion Animal Vaccines Market - Netherlands
    • 9.4.10.1. Netherlands: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.4.10.2. Netherlands: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.4.10.3. Netherlands: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.4.10.4. Netherlands: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.4.11. Companion Animal Vaccines Market - Russia
    • 9.4.11.1. Russia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.4.11.2. Russia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.4.11.3. Russia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.4.11.4. Russia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.4.12. Companion Animal Vaccines Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.4.12.2. Rest of Europe: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.4.12.3. Rest of Europe: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.4.12.4. Rest of Europe: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• 9.5. Companion Animal Vaccines Market - Asia Pacific
  • 9.5.1. Asia Pacific: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  • 9.5.2. Asia Pacific: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  • 9.5.3. Asia Pacific: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  • 9.5.4. Asia Pacific: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.5.5. Companion Animal Vaccines Market - China
    • 9.5.5.1. China: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.5.5.2. China: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.5.5.3. China: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.5.5.4. China: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.5.6. Companion Animal Vaccines Market - India
    • 9.5.6.1. India: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.5.6.2. India: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.5.6.3. India: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.5.6.4. India: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.5.7. Companion Animal Vaccines Market - Malaysia
    • 9.5.7.1. Malaysia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.5.7.2. Malaysia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.5.7.3. Malaysia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.5.7.4. Malaysia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.5.8. Companion Animal Vaccines Market - Japan
    • 9.5.8.1. Japan: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.5.8.2. Japan: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.5.8.3. Japan: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.5.8.4. Japan: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.5.9. Companion Animal Vaccines Market - Indonesia
    • 9.5.9.1. Indonesia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.5.9.2. Indonesia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.5.9.3. Indonesia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.5.9.4. Indonesia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.5.10. Companion Animal Vaccines Market - South Korea
    • 9.5.10.1. South Korea: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.5.10.2. South Korea: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.5.10.3. South Korea: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.5.10.4. South Korea: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.5.11. Companion Animal Vaccines Market - Australia
    • 9.5.11.1. Australia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.5.11.2. Australia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.5.11.3. Australia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.5.11.4. Australia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.5.12. Companion Animal Vaccines Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.5.12.2. Rest of Asia Pacific: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.5.12.3. Rest of Asia Pacific: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.5.12.4. Rest of Asia Pacific: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• 9.6. Companion Animal Vaccines Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  • 9.6.2. Middle East & Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  • 9.6.3. Middle East & Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  • 9.6.4. Middle East & Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.6.5. Companion Animal Vaccines Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.6.5.2. Saudi Arabia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.6.5.3. Saudi Arabia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.6.5.4. Saudi Arabia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.6.6. Companion Animal Vaccines Market - UAE
    • 9.6.6.1. UAE: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.6.6.2. UAE: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.6.6.3. UAE: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.6.6.4. UAE: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.6.7. Companion Animal Vaccines Market - Israel
    • 9.6.7.1. Israel: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.6.7.2. Israel: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.6.7.3. Israel: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.6.7.4. Israel: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.6.8. Companion Animal Vaccines Market - South Africa
    • 9.6.8.1. South Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.6.8.2. South Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.6.8.3. South Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.6.8.4. South Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.6.9. Companion Animal Vaccines Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.6.9.2. Rest of Middle East & Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.6.9.3. Rest of Middle East & Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.6.9.4. Rest of Middle East & Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
• 9.7. Companion Animal Vaccines Market - Latin America
  • 9.7.1. Latin America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
  • 9.7.2. Latin America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
  • 9.7.3. Latin America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
  • 9.7.4. Latin America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.7.5. Companion Animal Vaccines Market - Mexico
    • 9.7.5.1. Mexico: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.7.5.2. Mexico: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.7.5.3. Mexico: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.7.5.4. Mexico: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.7.6. Companion Animal Vaccines Market - Brazil
    • 9.7.6.1. Brazil: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.7.6.2. Brazil: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.7.6.3. Brazil: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.7.6.4. Brazil: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.7.7. Companion Animal Vaccines Market - Argentina
    • 9.7.7.1. Argentina: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.7.7.2. Argentina: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.7.7.3. Argentina: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.7.7.4. Argentina: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
  • 9.7.8. Companion Animal Vaccines Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
    • 9.7.8.2. Rest of Latin America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
    • 9.7.8.3. Rest of Latin America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
    • 9.7.8.4. Rest of Latin America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Bimeda Biologicals
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Boehringer Ingelheim Animal Health
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Calier
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Ceva
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Elanco
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Merck & Co., Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Neogen Corporation
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Phibro Animal Health Corporation
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Virbac
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Zoetis
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development